Evidence map›Paper›PMID 37515654›Full record

ReviewInflammopharmacology2024

Narcotic analgesics.

W Watson Buchanan, K D Rainsford, Colin A Kean, Walter F Kean

Abstract readReview
PubMed Publisher
In one paragraph

Review in Inflammopharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Enhancing recovery: surgical techniques and rehabilitation strategies after direct anterior hip arthroplasty.Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology · 2024
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

W Watson BuchananDepartment of Medicine, McMaster University, Hamilton, ON, L8P 1H6, Canada.
K D RainsfordSheffield Hallam University, Sheffield, S1 1WB, UK.
Colin A KeanHaldimand War Memorial Hospital, 400 Broad Street, Dunnville, ON, N1A 2P7, Canada.
Walter F KeanDepartment of Medicine, McMaster University, Hamilton, ON, L8P 1H6, Canada. wfkean@gmail.com.ORCID http://orcid.org/0009-0001-2621-3595

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is documentation of the use of opium derived products in the ancient history of the Assyrians: the Egyptians; in the sixth century AD by the Roman Dioscorides; and by Avicenna (980-1037). Reference to opium like products is made by Paracelsus and by Shakespeare. Charles Louis Derosne and Fredrich Wilhelm Adam Serturner isolated morphine from raw opium in 1802 and 1806 respectively, and it was Sertürner who named the substance morphine, after Morpheus, the Greek God of dreams. By the middle 1800s, Opium and related opioid derived products were the source of a major addiction in USA, and to some extent in the United Kingdom. Opioid products are of major therapeutic value in the treatment of pain from injury, post surgery, intractable pain conditions, and some forms of terminal cancer.

Indexed as

Analgesics, OpioidNarcoticsHumansMorphineOpiumAnalgesics, OpioidMorphineNarcoticsOpiumCodeineHeroinMorphineNarcoticsOpiumPain

Identifiers

PMID37515654

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.